Company: XTIA
Filing Date: 2025-04-18
Form Type: POS AM
Source: 0001213900-25-033058
Chunk: 22

Company: XTI Aerospace, Inc.
Filing Date: 2025-04-18
Form: POS AM
Chunk 22
---
   |       |   |     | $ |    2.30 |
| Dilution in net tangible book value per share to investors exercising Placement Agent Warrants  |     |   |       |   |     | $ | 14.8875 |
| Dilution in net tangible book value per share to investors exercising Pre-funded Warrants       |     |   |       |   |     | $ |       — |
| Dilution in net tangible book value per share to investors exercising Common Warrants           |     |   |       |   |     | $ |       — |
| Dilution in net tangible book value per share to investors exercising Representative Warrants   |     |   |       |   |     | $ |       — |

The number of shares of Common Stock is based on
1,685,021 shares of our Common Stock outstanding as of December 31, 2024, and excludes as of that date:

| ● | 51,185 shares of Common Stock issuable upon the exercise of                          
 outstanding stock options at a weighted average exercise price of $455.00 per share; |

| ● | 1,128 shares of Common Stock issuable upon the exercise of                         
 outstanding warrants at a weighted average exercise price of $20,343.35 per share; |

<div align='center'>7</div>

| ● | 38,359 shares of Common Stock available for future issuance                                                                          
 under our 2018 Employee Stock Incentive Plan and any other additional shares of our Common Stock that may become available under our 
 2018 Employee Stock Incentive Plan;                                                                                                  |

| ● | 1 share of Common Stock issuable upon the conversion of 1                                                       
 outstanding share of Series 4 Convertible Preferred Stock, at a conversion price of $418,500,000 per share; and |

| ● | 1 share of Common Stock issuable upon conversion of 126 outstanding                              
 shares of Series 5 Convertible Preferred Stock, at a conversion price of $280,968,750 per share. |

To the extent our outstanding
options and warrants (other than the Warrants) are exercised, you may experience further dilution. The above illustration of dilution
per share to investors participating in this offering assumes no exercise of outstanding options or outstanding warrants to purchase shares
of our Common Stock (other than the Warrants). The exercise of outstanding options and warrants having an exercise price less than the
exercise prices of the Warrants would further increase dilution to